*ADVENTRX Pharma Receives Refuse To File Letter From FDA On ANX-530 New Drug Application

This is bad short term news for ANX. I've been waiting for this moment for a long time now. This is my chart of ANX that I will be using for potential support. The next retracement level is .18 and which is confirmed by the 200dma. Support is also found in there. I will be watching for a bounce from this level